1.Surgical Treatment of Parkinson's Disease.
Journal of the Korean Neurological Association 1986;4(1):38-42
No abstract available.
Parkinson Disease*
2.The Modern Medical Treatment of Parkinson's Disease.
Journal of the Korean Neurological Association 1986;4(1):28-37
No abstract available.
Parkinson Disease*
3.Treatment of Parkinson's Disease.
Joo Hyuk IM ; Ji Hoon KANG ; Myoung Chong LEE
Journal of the Korean Neurological Association 2001;19(4):315-336
No abstract available.
Parkinson Disease*
4.Prevalence of pain and depression and their coexistence in patients with early stage of Parkinson’s disease
Shinji Ohara ; Ryoichi Hayashi ; Katsuhiko Kayanuma ; Harumi Kuwabara ; Kotaro Aizawa ; Hiroshi Koshihara ; Kenya Oguchi ; Yo-ichi Takei ; Naoko Tachibana
Neurology Asia 2015;20(4):355-361
Depression and pain are common and often early non-motor symptoms of Parkinson disease (PD).
The relationship between pain and depression in PD has been unsettled, with conflicting findings.
The PD patients followed up at the general neurology outpatient clinics were requested to complete
Beck Depression Inventory (BDI) and McGill pain questionnaire. The patients were categorized in
three groups according to the Hoehn-Yahr (H-Y) stage of PD; mild (stage I&II), moderate (stage III)
and advanced stage (stage IV&V), and group comparisons were performed in each group between
those with and without pain. A total of 186 patients completed the questionnaires. Their mean age was
74±9.3 years, and the mean H-Y stage was 2.8±0.8.Sixty-nine percent of the patients reported pain
symptoms of various natures. The BDI scores were significantly higher in the pain group (P< 0.0001)
despite the absence of statistically significant differences in the mean age, H-Y stage, and duration of
illness. Only PD patients of mild stage revealed significant difference of BDI scores between those
with pain and without pain (P <0.001). Our results showed that pain is a common symptom in patients
with PD and suggest that it may be related to depression in the early stage of the disease.
Parkinson Disease
5.Non-motor symptoms in Thai Parkinson’s disease patients and the correlation with motor symptoms
Pawut Mekawichai ; Salintip Kunadisorn ; Chaiwiwat Tungkasereerak ; Surin Saetang
Neurology Asia 2016;21(1):41-46
Background and objective:to identify the prevalence of non-motor symptoms (NMS) and to determine the
association between NMS and motor symptoms in Thai Parkinson’s disease (PD) patients. Methods: A cross
sectional study was performed in PD patients at Maharat Nakhon Ratchasima Hospital between January-June
2014. The NMS were assessed by using Non-Motor Symptoms Questionnaire-Thai version. All data were
analyzedfor identifying the prevalence of NMS and determining the correlation between NMS and motor
symptoms. Results:One hundred thirty six PD patients were enrolled. The severity of disease according to
Modified Hoehn and Yahr (MHY) was 1-1.5=33.1% of the patients, 2-2.5=52.2% and 3-5=14.7%. All patients
(100%) had NMS with mean number of 13.2±6.7 symptoms (ranging from 1-29). Nocturia was the commonest
symptom (82.4%), followed by constipation (74.3%) and forgetfulness (69.9%). Bowel incontinence was
the least frequent symptom (19.9%). Sleep disorder was the mostprevalent domain (92.6%), followed by
digestive domain (91.9%) and urinary domain (89.0%). The number of NMS significantly increased with
the degree of severity of disease and was higher in patients with motor complications.
Conclusion:NMS were reported by every Thai PD patients, and at all stage of the disease. Nocturia symptom
and sleep disorder domain were the most frequent NMS. The number of NMS strongly correlated with
motor complications and the severity of motor symptoms. However the presence of motor complications
appears to have stronger association with some NMS domains than the motor severity
Parkinson Disease
6.Importance of proper window setting in visual assessment of dopamine transporter imaging: A case of early-onset Parkinsonism related to Park2 gene mutation
Aryun Kim ; Han-Joon Kim ; Beomseok Jeon
Neurology Asia 2016;21(2):187-189
In the early stages or atypical manifestation of parkinsonism, dopamine transporter imaging can assist
the early diagnosis. We describe a 19 year-old man presenting with progressive gait disturbance,
cervical dystonia and head tremor. 18F-FP-CIT PET (FluoroPropyl-Carbomethoxylodopropyl-nor-BTropane
positron emission tomography) was done and interpreted as normal at other hospital, and his
diagnosis remained baffling. He visited our hospital several months later, and the FP-CIT PET image
was reviewed by the nuclear medicine physician in our hospital, who also interpreted it as normal.
However, we reviewed his FP CIT-PET image because his clinical picture was strongly suggestive of
juvenile parkinsonism. After adjusting the window setting of the PET image, we could appreciate the
decreased uptake in the bilateral basal ganglia. Thus he was finally diagnosed as juvenile parkinsonism
and gene test confirmed Park2 gene mutation. In conclusion, proper window setting is important during
visual assessment of dopamine transporter imaging.
Parkinson Disease
7.Hypometabolism based on a cutoff point on the mini-mental state examination in Parkinson’s disease
Eun Joo Chung ; Yong Hee Han ; Chi WoongMun ; Sang Kyun Bae ; Seok Mo Lee ; Hae Woong Jeong MD, Sang Jin Kim
Neurology Asia 2016;21(3):247-253
Objective: The aim of the present study was to evaluate cortical hypometabolism of the F-18-
fluorodeoxyglucose positron emission tomography (FDG-PET) based on a diagnostic cutoff point of
the mini-mental state examination (MMSE) in de novo PD.Methods: We recruited 24 PD patients and
15 healthy controls to analyze FDG-PET. We divided the patients into two groups by the diagnostic
cutoff point of MMSE for diagnosing dementia, with scores of>25 vs. < 25. FDG-PET was processed
using statistical parametric mapping (SPM) 8 running on Matlab 11. Results: Patients with a MMSE <
25 presented lower score in time orientation, serial sevens, language and pentagon copying of MMSE
compared to patients with a MMSE >25. Compared to healthy controls, patients with a MMSE> 25
and < 25 showed a fronto-temporo-parietal hypometabolism, which was more extended in patients
with a MMSE < 25. Difference in cortical hypometabolism between patients with a MMSE >25 and
< 25 was found in the right inferior parietal lobule.
Conclusions: In the comparison by cutoff point of MMSE (25/24), hypometabolism in the right
inferior parietal lobule suggests that the posterior cortical deficit is the main region ofde novo PD
with cognitive impairment. Hypometabolism of right inferior parietal lobule is related to the damage
of cerebral networkin de novo PD.
Parkinson Disease
8.Volume estimation of the subcortical structures in Parkinson’s disease using magnetic resonance imaging: A methodological study
Tolga Ertekin ; Niyazi Acer ; Semra çer ; Ümit Erkan Vurdem ; erife Çınar ; Özlem Özçelik
Neurology Asia 2015;20(2):143-153
Background & Objectives: Parkinson’s disease (PD) is the most prevalent neurodegenerative disorder,
beginning in the in the substantia nigra and spreading to the subcortical structures to the limbic cortices,
and eventually to the neocortex and is characterized clinically by tremor at rest, bradykinesia, and
rigidity. Regional brain atrophy is found to be an important marker of PD’s pathology. The aim of the
current study was to compare the volumes of subcortical brain structures between healthy subjects
and patients with PD using stereological (point-counting) and semi-automated segmentation methods.
Methods: Twenty-four patients with PD and 23 age matched healthy subjects free of any psychiatric,
neurological or cognitive impairment were included in our study. Magnetic resonance images were
analyzed by using two methods. Results: Both methods showed a decrease in volume of caudate nucleus
and lentiform nucleus in PD group compared to the control group. (p˂0.05). However, no significant
differences was found between patient and control groups for the volume of thalamus (p>0.05). Also,
no significant difference was found between point-counting and semi-automated segmentation methods
for the volumes of subcortical structures in both two groups (p>0.05).
Conclusion: Magnatic resonance imaging is helpful to facilitate the diagnosis in vivo of patients with
PD, revealing atrophy of specific brain regions such as caudate nucleus and lentiform nucleus.
Parkinson Disease
9.Can Olfactory Tests Help to Diagnose Parkinson Disease?
Clinical and Experimental Otorhinolaryngology 2019;12(2):105-106
No abstract available.
Parkinson Disease
10.Research on the structural characteristics and influencing factors of sleep disorders in Parkinson disease
Journal of Apoplexy and Nervous Diseases 2024;41(3):209-214
Objective To investigate the incidence rate of sleep disorders, the features of sleep structure, and related influencing factors in patients with Parkinson disease (PD).Methods A total of 101 patients with PD who attended the outpatient services or were hospitalized in Department of Neurology, The First Hospital of Hebei Medical University, from August 2016 to April 2022 were enrolled as subjects, and Unified Parkinson Disease Rating Scale Part Ⅲ (UPDRS-Ⅲ) and Hoehn-Yahr (H-Y) staging were used to evaluate motor function and disease severity. The patients with PD were tested using Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), International Restless Legs Scale (IRLS), and rapid eye movement sleep behavior disorder (RBD) scale, and related information was collected or measured, including body height, body weight, body mass index (BMI), neck circumference, abdominal circumference, and past medical history. All patients received standardized nocturnal polysomnography (PSG).Results Among the 101 patients with PD, 87 (86.14%) had sleep disorders. PSG showed that common sleep disorders included RBD,periodic limb movements (PLM), and obstructive sleep apnea-hypopnea syndrome (OSAHS). For the PD patients with RBD,the proportion of rapid eye movement sleep was (13.14±8.11)%, with poor subjective sleep quality and obvious depression. PLM was often comorbid with restless legs syndrome in PD patients. OSAHS was more likely to occur in PD patients with greater neck circumference and abdominal circumference,and there was no obvious association between OSAHS and BMI; in addition,excessive daytime sleepiness was more common in PD patients with OSAHS,which had a greater impact on the daytime function of the patents.Conclusion There is a relatively high incidence rate of sleep disorders in PD patients, and PD patients with sleep disorders often have the manifestations of RBD,PLM and OSAHS. PD patients with RBD tend to have poor sleep quality and obvious depression, and OSAHS is more likely to occur in PD patients with greater neck circumference and abdominal circumference,which is not significantly associated with BMI.
Parkinson Disease